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Abstract
Glutamate is emerging as a major factor stimulating energy production in CNS. Brain mitochondria can utilize this
neurotransmitter as respiratory substrate and specific transporters are required to mediate the glutamate entry into the
mitochondrial matrix. Glutamate transporters of the Excitatory Amino Acid Transporters (EAATs) family have been
previously well characterized on the cell surface of neuronal and glial cells, representing the primary players for glutamate
uptake in mammalian brain. Here, by using western blot, confocal microscopy and immunoelectron microscopy, we report
for the first time that the Excitatory Amino Acid Carrier 1 (EAAC1), an EAATs member, is expressed in neuronal and glial
mitochondria where it participates in glutamate-stimulated ATP production, evaluated by a luciferase-luciferin system.
Mitochondrial metabolic response is counteracted when different EAATs pharmacological blockers or selective EAAC1
antisense oligonucleotides were used. Since EAATs are Na
+-dependent proteins, this raised the possibility that other
transporters regulating ion gradients across mitochondrial membrane were required for glutamate response. We describe
colocalization, mutual activity dependency, physical interaction between EAAC1 and the sodium/calcium exchanger 1
(NCX1) both in neuronal and glial mitochondria, and that NCX1 is an essential modulator of this glutamate transporter. Only
NCX1 activity is crucial for such glutamate-stimulated ATP synthesis, as demonstrated by pharmacological blockade and
selective knock-down with antisense oligonucleotides. The EAAC1/NCX1-dependent mitochondrial response to glutamate
may be a general and alternative mechanism whereby this neurotransmitter sustains ATP production, since we have
documented such metabolic response also in mitochondria isolated from heart. The data reported here disclose a new
physiological role for mitochondrial NCX1 as the key player in glutamate-induced energy production.
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Introduction
The increase in brain metabolism that takes place in response to
sensory stimulation [1] may be related to the activation of
glutamatergic pathways [2]; however, the mechanisms underpin-
ning glutamate release at the synapse and energy production in the
brain are still ill defined. According to the classic astrocyte-neuron
lactate shuttle hypothesis, neuronal metabolism is sustained by
lactate, generated by neighboring astrocytes after exposure to
glutamate [3]. However, since lactate concentrations do not rise,
but actually decrease shortly after activation [4], this theory has
recently been questioned [5,6] and the concept of compartmen-
tation of intermediary metabolism in the brain has become
increasingly controversial [7,8,9,10,11]. An alternative, intriguing
hypothesis is that glutamate could be responsible per se for
enhancing activity-triggered metabolism in the brain [10].
Several members of the gene family EAATs encode transporters
that play an important role in the regulation of the extracellular
concentration of glutamate [12]. In fact, EAAT carriers located on
presynaptic and postsynaptic terminals, as well as on glial cells,
rapidly remove most of the released glutamate from the synaptic
cleft [13,14]. Therefore, during synaptic activity, neuronal and
astroglial mitochondria can be temporarily exposed to increased
levels of glutamate that in the synaptic cleft can reach low
millimolar range following vesicles release [12]. Consequently,
mitochondria from both neurons and astrocytes can utilize
glutamate as alternative respiratory substrate [15,16]. In fact
glutamate, after being transaminated to a-ketoglutarate, fuels
oxidative metabolism maintaining the levels of the Krebs cycle
intermediates [17].
It is generally accepted that glutamate enters into the
mitochondrial matrix mainly via the aspartate/glutamate carriers
(AGCs), a required component of the malate/aspartate shuttle
(MAS) [18,19]. However, recently it has been proposed that in
heart tissue glutamate may enter mitochondria through EAATs
[20,21]. EAATs co-transport Na
+ and glutamate, using the
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+ gradient to carry glutamate across the membrane
[14]; this raise the question how the Na
+ gradient can be
maintained. We previously described the mitochondrial expression
of the Na
+/Ca
2+ exchanger (NCX) plasma membrane isoforms
[22,23,24]. NCX is a reversible transporter that can move Na
+
across the membrane in exchange for Ca
2+, and the direction of
ions movement depends upon the electrochemical ion gradients
[22,25,26,27].
Based on the findings reported above, we hypothesized that
members from EAATs localize with NCX transporters within
brain mitochondria, representing an alternative and regulated
mechanism by which glutamate enters mitochondrial matrix. We
tested this hypothesis by coimmunoprecipitating EAAC1/NCX1
complexes in purified hippocampal and cortical mitochondria. In
addition, we also studied the pharmacological properties and
functional interaction between EAAC1 and NCX1 and our
findings support the idea that the close coupling between these
transporters regulates glutamate-stimulated mitochondrial ATP
production in brain. Similar results were also obtained in isolated
heart mitochondria, supporting the idea that selective interaction
between EAAC1 and NCX1 may be a rather general mechanism
in tissues where both of these transporters are expressed.
Results and Discussion
Glutamate ability to stimulate ATP synthesis in purified
rat brain mitochondria
To establish whether glutamate enhances oxidative metabolism
by a direct mitochondrial effect, we exposed purified mitochondria
(Figure 1A) from rat hippocampus and cortex, two regions thought
to be among the most sensitive to the neurotransmitter [28], to
1 mM exogenous glutamate. We found that ATP synthesis
increased significantly in mitochondria from both regions
(Figure 1B) and that it depended on the activation of oxidative
metabolism, as demonstrated by its abrogation by the F1FO-ATP
synthase inhibitor oligomycin [29] (Figure 1B). To exclude a
dependence of glutamate-induced ATP synthesis in mitochondria
on possible cytoplasm contamination of our preparations, we
performed experiments with glucose, which requires cytosolic
glycolytic enzymes [30] and was, as expected, unable to induce
ATP synthesis (Figure 1C). Moreover we found that in isolated
mitochondria lactate dehydrogenase (LDH) activity was virtually
undetectable, strengthening the absence of cytosol contamination
(data not shown).
EAATs involvement in glutamate-stimulated ATP
synthesis
Since glutamate transamination to a-ketoglutarate takes place in
the mitochondrial matrix [17], the question arises of how it
accesses this compartment. The mechanisms responsible for its
transport have been well characterized in the neuronal and glial
plasma membrane, leading to identification of a family of highly
specialized proteins, the Excitatory Amino Acid Transporters
(EAATs), which are Na
+-dependent glutamate transporters [31].
Therefore, we explored the possibility that EAATs could also be
involved in glutamate transport in brain mitochondria, a process
that is held to be mediated by the aspartate/glutamate carriers
(AGCs) Aralar/AGC1 and Citrin/AGC2 [32]. Interestingly, we
found that the glutamate-stimulated ATP synthesis in rat
hippocampal and cortical mitochondria was inhibited by the
selective non-transportable EAATs blocker DL-TBOA
[33,34,35,36,37] (Figure 1D) in a dose-dependent manner (data
not shown). In addition, three different EAATs were detected in
protein extracts of hippocampal and cortical mitochondria,
namely GLutamate ASpartate Transporter (GLAST), Glutamate
Transporter 1 (GLT1) and EAAC1 (Figure 1E). To assess the role
of mitochondrial EAATs in sustaining energy metabolism under
physiological conditions, we further tested the ability of glutamate
to stimulate ATP production even in the presence of other
metabolic intermediates such as malate and pyruvate [38]. As
shown in Figure 2A, at sub-saturating concentration (0.1 mM)
malate and pyruvate increased ATP production in hippocampal
and cortical mitochondria. The ATP levels reached in the
presence of glutamate plus malate and pyruvate were significantly
higher than those achieved with malate plus pyruvate (Figure 2A).
Moreover, TFB-TBOA, another selective non-transportable
EAAT inhibitor [35,39], completely blocked the glutamate-
dependent component of such stimulation, without affecting the
ability of malate plus pyruvate to sustain ATP production
(Figure 2A). When malate and pyruvate were used at saturating
concentrations (determined by exposing isolated mitochondria to
different concentrations of malate and pyruvate, from 0.1 up to
3 mM, with maximal response reached already at 0.3 mM) (data
not shown), glutamate was still able to induce an ATP response
specifically abolished by TFB-TBOA (Figure 2B). Collectively
these data suggest that the ability of glutamate in sustaining
mitochondrial ATP production via EAATs is preserved both at
sub-saturating and saturating concentration of other metabolic
intermediates such as malate and pyruvate.
Since mitochondrial preparations from hippocampal and
cortical regions contained mitochondria from both neurons and
glia, we wondered whether the effect of glutamate was to be
ascribed solely to neuronal mitochondria, or whether glial
mitochondria were also involved. To dissect this effect we
measured the ATP synthesis stimulated by exogenous glutamate
in mitochondria isolated from two different continuous cell lines,
one purely neuronal, human SH-SY5Y neuroblastoma cells, and
one purely glial, rat C6 glioma cells, and found a significant
increase in ATP production in both systems (Figure 3A). These
preparations were not contaminated by cytosol, since glucose was
unable to stimulate ATP production whereas it was effective in
intact cells (Figure S1). In addition LDH activity was virtually
absent (data not shown). Glutamate therefore appears to stimulate
mitochondrial metabolism both in neurons and in glia, suggesting
that an increase in oxidative metabolism may be a general
response mechanism to the activation of glutamatergic neuro-
transmission.
Glutamate entry into mitochondria is sustained by
EAAC1 activity
DL-TBOA does not discriminate between GLAST, GLT1 and
EAAC1, and, therefore, does not provide any information as to
which subtype(s) was involved in mediating the effect of glutamate
on mitochondrial metabolism. However, EAAC1 protein was
detected in SH-SY5Y and C6 cell mitochondria (Figure 3B)
where, as in brain, DL-TBOA inhibited glutamate-stimulated
ATP synthesis (Figure 3A), whereas GLAST mRNA and protein
were barely detectable and GLT1 mRNA was virtually absent
(data not shown). To establish whether EAAC1 was the
transporter subtype mediating stimulation of glutamate-induced
metabolism, we investigated the effect of selective EAAC1 knock-
down with antisense oligonucleotides (AsODNs) on ATP respon-
siveness to glutamate in SH-SY5Y and C6 cells. Treatment with
EAAC1 AsODN completely abolished glutamate-induced ATP
synthesis in both systems (Figure 3C). Since selective knock-down
of EAAC1 (Figure S2) abrogated glutamate-stimulated ATP
synthesis, this ruled out an involvement of GLAST, suggesting
that the process relies solely on EAAC1. The latter observation
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e34015Figure 1. Glutamate-stimulated ATP synthesis in isolated mitochondria from rat tissues. (A) Purity of mitochondrial preparations: western
blot for the integral protein of the endoplasmic reticulum calnexin; for the plasma membrane protein b1 integrin; for the selective mitochondrial
markers porin and ANT in tissue homogenate or in Percoll gradient-purified mitochondria from hippocampus and cortex. (B) ATP production by
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cortex, since TFB-TBOA at a concentration of 50 nM, known to
block GLAST and GLT-1 without affecting EAAC1 [39], was
unable to counteract glutamate-stimulated ATP synthesis
(Figure 1F), whereas at a higher concentration able to inhibit
EAAC1, TFB-TBOA blocked glutamate-stimulated ATP synthesis
(Figure 2A). TFB-TBOA was unable to modify basal ATP levels
(data not shown). In addition, in isolated SH-SY5Y and C6
mitochondria, glutamate stimulated ATP production in a Na
+-
dependent manner (Figure 4). Finally, we explored the possible
involvement of AGCs. Real time experiments disclosed that SH-
SY5Y and C6 cells expressed only Citrin/AGC2 (data not shown);
we therefore used these cell lines in experiments where we knocked
down Citrin/AGC2 by transfecting human and rat specific ODNs,
respectively (Table 1 and Figure S2). These experiments failed to
document an involvement of the AGC pathway in glutamate-
dependent ATP production (Figure 3D) in our model.
mitochondria from rat hippocampus and cortex after 1 h incubation with glutamate (black bars) or vehicle (white bars) with or without oligomycin.
(C) ATP production by mitochondria from rat hippocampus and cortex after 1 h incubation with glutamate (black bars) or vehicle (white bars) or
different glucose concentrations (gray bars). (D) ATP production in rat hippocampal or cortical mitochondria exposed for 1 h to DL-TBOA in the
presence of glutamate (black bars) or vehicle (white bars). (E) GLAST, GLT1, and EAAC1 glutamate transporters in mitochondrial protein extracts (mt)
from rat hippocampus or cortex. Plasma membrane proteins (m) were used as a positive control. The same panel shows EAAC1 immunoreactivity in
different rat tissues. Rat testis were used as negative control. (F) ATP production in rat hippocampal or cortical mitochondria exposed for 1 h to TFB-
TBOA 50 nM in the presence of glutamate (black bars) or vehicle (white bars). Each bar in panels B, C, D, F represents the mean 6 SEM of 18 different
determinations. ** p,0.01 vs control; *** p,0.001 vs control; ## p,0.01 vs 1 mM glutamate; ### p,0.001 vs 1 mM glutamate.
doi:10.1371/journal.pone.0034015.g001
Figure 2. Glutamate-stimulated ATP synthesis in isolated mitochondria from rat tissues in the presence of malate and pyruvate. (A)
ATP production by mitochondria from rat hippocampus and cortex after 1 h incubation with 1 mM glutamate (G), 0.1 mM malate (M) plus 0.1 mM
pyruvate (P), or glutamate plus malate plus pyruvate (all the black bars). Grey bars represent the same experiment performed in the presence of TFB-
TBOA (3 mM), the white bar represents vehicle-exposed mitochondria. Each bar represents the mean 6 SEM of 20 different determinations. (B) ATP
production by mitochondria from rat hippocampus and cortex after 1 h incubation with 1 mM glutamate and/or saturating concentrations of malate
(2.5 mM) and pyruvate (2.5 mM) (black bars) in the presence of TFB-TBOA (3 mM) (grey bars). Each bar represents the mean 6 SEM of 12 different
determinations. *** p,0.001 vs control; # p,0.05 vs 1 mM glutamate; ### p,0.001 vs 1 mM glutamate; 111 p,0.001 vs M+P+G.
doi:10.1371/journal.pone.0034015.g002
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glutamate triggers metabolic activation by enhancing ATP
synthesis in glial and neuronal mitochondria, in a process
Figure 3. Glutamate-stimulated ATP synthesis in isolated
mitochondria from cells. (A) Effects of DL-TBOA on glutamate-
stimulated ATP synthesis in mitochondria from SH-SY5Y neuroblastoma
andC6 gliomacells. (B)EAAC1expression in SH-SY5Y neuroblastomaand
C6gliomacell mitochondria.Samples enrichedwith anti-EAAC1 antibody
by selective immunoprecipitation (IP) were also loaded onto the gel.
Protein extracts from rat brain andfrom BHKcells stablyexpressing NCX1
were used as controls. In each IP lane, the lower band represents the
immunoglobulin. (C) Effect of anti-EAAC1 (As-EAAC1) and anti-Citrin/
AGC22 (As-AGC2) antisense (D) ODNs, on glutamate-stimulated ATP
synthesis in SH-SY5Y neuroblastoma and C6 glioma cells. Data from cells
treated with Lipofectamine (Ctl) and sense ODNs (S-EAAC1 and S-AGC2)
are also reported. Each bar in panels A, C and D represents the mean 6
SEM of 14 different determinations. * p,0.05 vs control; ** p,0.01 vs
control; *** p,0.001 vs control; ## p,0.01 vs 0.5 or 1 mM glutamate;
### p,0.001 vs 0.5 or 1 mM glutamate; n.s.: not significant vs control.
In ODNs experiments, *** p,0.001 vs S+glutamate.
doi:10.1371/journal.pone.0034015.g003
Figure 4. Extramitochondrial sodium concentration affects
glutamate-induced ATP synthesis. Effect of different Na
+ concen-
trations on ATP synthesis in SH-SY5Y (A) and C6 (B) mitochondria. The
glutamate stimulatory effect on ATP synthesis, observed with 5 mM
Na
+, was lost when 1 mM Na
+ was used in the buffer solution, both in
SH-SY5Y and C6 mitochondria (panel A and B, respectively). Each bar
represents the mean 6 SEM of data from 9 different experimental
sessions. ATP data were normalized to the protein content of the
different mitochondrial preparations *** p,0.001 vs all groups.
doi:10.1371/journal.pone.0034015.g004
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Additional support for the mitochondrial localization of EAAC1
came from immunoelectron microscopy, showing the presence of
specific staining in neuronal and glial mitochondria in rat cerebral
cortex and hippocampus (Figures 5A–E). Notably, the specificity of
EAAC1 antibody was verified by looking for reactivity in different
rat tissues by western blot. As previously described EAAC1 was
not detected in rat testis [40] (Figure 1E). Moreover, the lack of
immunoreactivity demonstrated no cross-reaction with GLAST
and GLT-1, known to be expressed in the same tissue [40].
Table 1. Primer sequences used for real-time PCR reactions and chimeric phosphorotioated ODNs.
Gene Name
(GeneBank accession number) Sequence
Bases pairs
(bp)
Melting
Temperature Method
r NCX1
(NM_019268)
F: TCGCCTCCTCCAGCTCCTGC
R: GCTCCAGCCCATCATCGCGAC
390 Reverse transcription PCR
EAAC1
(D63772)
F: TGAGCATCAAGCCTGGTGTC
R: TCCCCAGTCTTCAACTTCTA
491 Reverse transcription PCR
GAPDH
(BC087743)
F: CCATGGAGAAGGCTGGGG
R:CAAAGTTGTCATGGATGACC
195 Reverse transcription PCR
EAAC1
(D63772)
F: GGTTCAAGCCCTAAAGCAGAAA
R: GGAGCTTGACCTTAGATGTTGT
72 78 Real Time PCR
Citrin/AGC2
(NM_014251; XM_342640)
F:GAAGCCTGCTCTTAGCTGGT
R:CTGTAAGTGGTTTGGCCAGC
117 82 Real Time PCR
GAPDH
(BC087743)
F: CCCCCAATGTATCCGTTGTG
R:TAGCCCAGGATGCCCTTTAGT
118 82.2 Real Time PCR
h EAAC1 (NM_004170) S: CCACCGTGGCCGCGGTGG
AS:CCACCGCGGCCACGGTGG
Transfection
r EAAC1 (NM_013032; XM_346583) S: GCTCGGGATGCGACTGGC
AS: GCCAGTCGCATCCCGAGC
Transfection
1 h Citrin/AGC2 (NM_014251) S:GTCAGTGGGTCCCGCAGTCG
AS: CGAGTGCGGGACCCACTGAC
Transfection
3 h/R Citrin/AGC2 (NM_014251) S: GTGGTGGATCAGACCAAAGA
AS: TCTTTGGTCTGATCCACCAC
Transfection
r Citrin/AGC2
(XM_342640)
S: GGCCGCGTGGGTGGCTTTAAC
AS: GTTAAAGCCACCCACGCGGCC
Transfection
r/h Citrin/AGC2 (NM_014251;
XM_342640)
S: GATTTATATGAGCCAAGGG
AS: CCCTTGGCACATATAAATC
Transfection
Table 1 footnote. Antisense (rAS EAAC1, hAS EAAC1, rAS Citrin/AGC22, hAS Citrin/AGC2, h/rAS Citrin/AGC2) and sense (rS EAAC1, hS EAAC1, rS Citrin/AGC2, hS Citrin/
AGC2, h/rS Citrin/AGC2) probes used to reduce EAAC1and Citrin/AGC2 expression. Boldface indicates phosphorotiated bases.
doi:10.1371/journal.pone.0034015.t001
Figure 5. EAAC1 Pre-embedding Immunoelectron Microscopy. (A–E) Specific staining (granular electron-dense reaction product) is present
on the membrane of some mitochondria (arrows) contained into the dendrites (a,b), neuronal somata (b,d) and astrocyte soma (c) and perivascular
processes (e) of both rat cerebral cortex (a–c) and hippocampus (d,e). Labeling is also scattered in the cytoplasm and present into cisterns of the
rough endoplasmic reticulum and Golgi apparatus (arrowheads, inset of b). Insets are the enlargement of the corresponding framed area. Den,
dendrite; Nuc, nucleus; G, Golgi apparatus; RER, rough endoplasmic reticulum; E, endothelium; F, filaments; Cap, capillary. Bar: a, 3 mm; b, 4 mm; c,
6 mm; d, 1.5 mm; e 2.5 mm; inset of a, 1 mm; inset of b, 2 mm; inset of c, 2.5 mm.
doi:10.1371/journal.pone.0034015.g005
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depolarization
Considering that substrate uptake by EAATs is electrogenic [31],
increased glutamate concentrationsin mitochondria areexpected to
result in significant depolarization of the inner mitochondrial
membrane as a consequence of Na
+ accumulation. This was
demonstrated by real-time confocal videoimaging experiments,
where TMRE [41,42,43], a selective indicator of inner mitochon-
drial membrane potential, showed that glutamate exposure of SH-
SY5Y and C6 cells resulted in significant depolarization (Figure 6A
and B). DL-TBOA did not modify the inner mitochondrial
membrane potential in resting condition (Figure 6C and D), but it
significantly inhibited the mitochondrial depolarization induced by
glutamate exposure, confirming the key role of Na
+/glutamate co-
transport in this response (Figure 6A and B).
In order to completely exclude any contamination of the
plasma membrane potential to the TMRE signals, we performed
a set of experiments with digitonin-permeabilized SH-SY5Y and
C6 cells. As shown in Figures 7A–D, when permeabilized cells
were exposed to glutamate, a rapid decrease in TMRE
fluorescence was observed (reflecting in these conditions mito-
chondrial depolarization) that reverted to baseline levels after
washout. Exposure to FCCP (5 mM) at the end of the experiments
abolished TMRE fluorescence, as expected. When the cells were
treated with DL-TBOA (300 mM), the glutamate-dependent drop
in DYmit was significantly prevented (Figures 7A–D) in agreement
with the TMRE data previously obtained in non permeabilized
cells.
Role played by sodium and calcium ions in glutamate-
stimulated ATP synthesis. Involvement of NCX
Since EAATs cotransport Na
+/glutamate using the favorable
Na
+ gradient to carry glutamate, their activity is expected to
diminish as Na
+ accumulates, and eventually to stop unless specific
mechanisms that preserve the Na
+ gradient are activated. Such a
mechanism has been documented in the totally different system of
neuronal and glial plasma membranes, where Na
+/K
+-ATPase
extrudes the Na
+ ions that are cotransported with glutamate
[3,44,45]. The main Na
+ efflux system in the brain mitochondrial
matrix in physiological conditions is the Na
+/H
+ exchanger (NHE)
[46], whose role in stemming glutamate-induced Na
+ build-up is
however presumably negligible, since H
+ is cotransported with
Na
+ while glutamate is transported by EAATs [12,31]. Accord-
ingly, selective pharmacological blockade of NHE with 10 mM5 -
(N-Ethyl-N-isopropyl)amiloride (EIPA) [47] did not affect gluta-
mate-stimulated ATP production in mitochondria isolated from
rat hippocampus and cortex (Figure 8A) and from SH-SY5Y and
C6 cells (data not shown).
Figure 6. Real-time membrane potential analysis in intact cells. Experiments performed in SH-SY5Y (A,C) and C6 (B,D) cells using quenching
concentration of the inner mitochondrial membrane potential indicator TMRE (150 nM). Glutamate perfusion induced mitochondrial depolarization
(blue line). DL-TBOA (100 mM) and CGP-37157 (3 mM) both perfused from 20 min before through the end of recordings, prevented glutamate-
stimulated mitochondrial depolarization (pink and yellow lines, respectively), while Ru360 (10 mM) was ineffective (green line). The resting condition
inner mitochondrial membrane potential of SH-SY5Y neuroblastoma (A) or C6 glioma (B) cells was not affected by DL-TBOA (pink line), CGP-37157
(yellow line) or Ru360 (green line). The respiratory chain poison p-trifluoromethyl phenyl hydrazone (FCCP, 5 mM) was added at the end as an internal
control in each experiment. For each group, more than 45 cells recorded in four different sessions were analyzed and the maximal depolarization
induced after glutamate stimulation was used for the statistical analysis. *** p,0.001 vs control.
doi:10.1371/journal.pone.0034015.g006
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support glutamate entry via (EAAC1) EAATs is the Na
+/Ca
2+
exchanger (NCX) [22]. In resting condition NCX extrudes Ca
2+
from the matrix in exchange for cytosolic Na
+, but it can reverse
its mode of operation in presence of increased Na
+ ion
concentrations [22,26,27]. Since Na
+ is cotransported with
glutamate, mitochondrial Na
+ (Na
+
mit) should increase. Monitor-
ing Na
+
mit levels with the Na
+-sensitive fluorescent probe CoroNa
Red [48] we found that glutamate exposure evoked a Na
+
mit
response both in SH-SY5Y neuroblastoma and in C6 glioma cells
(Figure 8B). Blockade of mitochondrial NCX conductance with its
selective inhibitor CGP-37157 [49] prevented the Na
+
mit increase
induced by glutamate (Figure 8B). In line with these results, NCX
blockade with CGP-37157, which alone was unable to modify the
inner mitochondrial membrane potential in resting condition
(Figure 6C and D), significantly blunted the mitochondrial
depolarization induced by glutamate (Figure 6A and B and
Figures 7A–D). Altogether these results suggest that a functional
mitochondrial NCX is required for such responses.
To further explore the physiological significance of such close
association of NCX and EAAC1 in mitochondria we tested the
effect of CGP-37157 on glutamate-induced ATP synthesis in rat
hippocampal and cortical mitochondria, and found a dose-
dependent reduction (Figure 8C) with an IC50 (0.29 and
0.36 mM, respectively) that was very close to the value reported
for inhibition of NCX activity in mitochondria [49]. Similar results
were obtained in SH-SY5Y and C6 cell mitochondria (Figure 8D).
These data show that NCX activity is critical for glutamate-
induced ATP synthesis in mitochondria, possibly because
mitochondrial NCX preserves the Na
+ gradient required for
glutamate transport.
Mitochondrial sodium accumulation and mitochondrial mem-
brane depolarization, observed during glutamate exposure, are
two conditions that may favor the reverse mode of operation of
NCX which, in turn, will tend to bring Ca
2+ into the
mitochondria. An increase in Ca
2+
mit would also increase ATP
synthesis enhancing mitochondrial dehydrogenase activity [27,50].
Therefore, we measured Ca
2+
mit in digitonin permeabilized cells
before and after glutamate exposure. As reported in Figure 9,
glutamate significantly increased Rhod-2 fluorescence in permea-
bilized SH-SY5Y and C6 cells (respectively, 19 and 15%).
Finally, we explored the possibility that the Ca
2+ uniporter,
another Ca
2+ entry route into the mitochondrial matrix [27,46],
may also be involved in glutamate-enhanced ATP synthesis.
However, the uniporter does not seem to participate in this
process, since its selective blockade with Ru-360 [51] (10 mM) did
not affect glutamate-induced ATP synthesis either in hippocampal
or in cortical mitochondria (Figure 8E). Moreover, Ru-360
Figure 7. Real-time membrane potential analysis in permeabilized cells. Experiments performed in digitonin-permeabilized SH-SY5Y (A,B)
and C6 (C,D) cells using TMRE at non-quencing concentration (10 nM). Glutamate perfusion induced a mitochondrial depolarization (blue line). Both
DL-TBOA (300 mM) and CGP-37157 (3 mM) prevented the glutamate-stimulated mitochondrial depolarization (pink and yellow lines, respectively).
FCCP (5 mM) was added at the end as an internal control in each experiment. Mitochondria response was analyzed as the ratio of fluorescence during
maximal glutamate depolarization versus pre stimulus levels. Each bar represents the mean 6 SEM of 50–100 cells recorded in 5 different sessions
(B,D). *** p,0.001 vs control.
doi:10.1371/journal.pone.0034015.g007
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chondrial depolarization (Figure 6A and B). Ru-360 (10 mM) alone
did not affect the inner mitochondrial membrane potential in
resting condition (Figure 6C and D).
In mitochondria EAAC1 and NCX1 are parts of a
multimolecular complex
We have recently shown that the three gene products of the
plasma membrane Na
+/Ca
2+ exchanger, NCX1, NCX2 and
NCX3, also localize to the inner mitochondrial membrane
[22,23,24]. We speculated that interaction of any of the NCX
proteins with mitochondrial EAATs would entail its close
association with them. We thus performed immunoprecipitation
studies on hippocampal and cortical mitochondrial extracts using
antibodies against GLAST, GLT1 and EAAC1 and then sought
NCX immunoreactivity. Strong NCX1 immunoreactivity was
found in the EAAC1 antibody precipitates (Figure 10A); in line
with these results EAAC1 was pulled down by NCX1 antibody on
reverse immunoprecipitation (Figure 10B). These data suggest that
a multimolecular complex made up of EAAC1 and NCX1 exists
in hippocampal and cortical mitochondria, and several lines of
evidence strongly support the selectivity and specificity of such
interaction. First, the EAAC1 antibody pulled down neither
NCX2 nor NCX3 (Figure 10A). Second, the NCX1 antibody
Figure 8. NCX dependence of glutamate-stimulated ATP synthesis. (A) The NHE blocker EIPA (10 mM) was not able to affect baseline (white
bars) and glutamate-stimulated (black bars) ATP synthesis in mitochondria isolated from rat hippocampus or cortex. (B) The bar graphs illustrate the
glutamate-dependent Na
+
mit response in SH-SY5Y and C6 cells in the control condition and after 20 min exposure to CGP-37157 (3 mM). Na
+
mit
response to the glutamate challenge was measured as the percent increase from resting Na
+
mit (D%), i.e. from the mean Na
+
mit recorded during the
120 s preceding the challenge to the highest Na
+
mit value reached after glutamate stimulation. The insets report representative records of glutamate
induced Na
+
mit response obtained in SH-SY5Y and C6 cells, under control condition (pink line) and after CGP-37157 treatment (blue line). Each bar
represent the mean 6 SEM of 48–58 cells recorded in 3 different experimental sessions. *** p,0.001 vs control. (C) Effects of rising concentrations of
the mitochondrial NCX blocker CGP-37157 on glutamate-stimulated ATP synthesis in mitochondria from rat hippocampus or cortex; similar results
were obtained in mitochondria isolated from SH-SY5Y and C6 cells (D). (E) The Ca
2+ uniporter inhibitor Ru360 (10 mM) was not able to affect baseline
(white bars) and glutamate-stimulated (black bars) ATP synthesis in mitochondria isolated from rat hippocampus or cortex. Each bar represents the
mean 6 SEM of 10 different determinations. * p,0.05 vs control; *** p,0.001 vs control; # p,0.05 vs 0.5 or 1 mM glutamate; ### p,0.001 vs 0.5
or 1 mM glutamate.
doi:10.1371/journal.pone.0034015.g008
Figure 9. Real-time Ca
2+
mit measurements in permeabilized cells. Experiments performed in digitonin-permeabilized SH-SY5Y (A,B) and C6
(C,D) cells using Rhod-2 (5 mM). As indicated by the increase in Rhod-2 fluorescence, glutamate perfusion induced mitochondrial Ca
2+ increase both
in SH-SY5Y (A,B) and C6 cells (C,D). Mitochondria response was analyzed as the ratio of fluorescence during maximal glutamate stimulation versus pre
stimulus levels. Each bar represents the mean 6 SEM of .80 cells recorded in 4 different sessions. *** p,0.001 vs basal.
doi:10.1371/journal.pone.0034015.g009
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mitochondrial extracts were pulled down with normal mouse
serum (obtained from non-immune animals), we were unable to
detect NCX1, EAAC1, GLAST or GLT1 (Figure 10A and B).
Fourth, mitochondrial extracts pulled down with EAAC1 or NCX
1 antibodies did not contain adenine nucleotide translocase (ANT),
another inner mitochondrial membrane protein [52] (Figure S3),
suggesting that the EAAC1 antibody does not recognize non-
specific mitochondrial components and confirming that the
association of EAAC1 and NCX1 found in mitochondria was
specific. The coimmunoprecipitation data were confirmed on
mitochondrial extracts from SH-SY5Y neuroblastoma and C6
glioma cells (Figure 10C). The hypothesis that EAAC1 and NCX1
could coassemble in neuronal and glial mitochondria was
strengthened by confocal experiments showing their consistent
colocalization in immunofluorescence studies performed on
isolated mitochondria spotted on glass micro slides (Figure 10D).
NCX1 dependence of glutamate-stimulated ATP
synthesis
SH-SY5Y cells express NCX1 and NCX3 [53] (data not
shown), while C6 cells express all three NCX (data not shown). To
establish whether the privileged association of EAAC1 and NCX1
emerging from the immunoprecipitation experiments also corre-
Figure 10. EAAC1 and NCX1 are assembled into a multimolecular complex in mitochondria. (A) Selective NCX1 immunoprecipitation by
EAAC1 antibody in mitochondrial protein extracts from rat cortex and hippocampus. Three different western blots experiments using NCX1, NCX2 or
NCX3 antibodies are reported. The gels were loaded with mitochondrial crude protein extracts (mt) or with EAAC1-immunoprecipitated proteins (mt-
IP EAAC1). For western blots resolved with NCX1 antibody, brain tissue homogenate (brain) and normal mouse serum-immunoprecipitated proteins
(mt-IP NM) were used as a positive and a negative control, respectively. For NCX2 and NCX3, proteins from isolated membranes (m) or EAAC1-
immunoprecipitated membranes (m-IP EAAC1) were also analyzed. (B) Mitochondrial protein extracts (from the same preparations used in panel A)
immunoprecipitated with NCX1 antibody and resolved with GLAST, GLT1 and EAAC1 antibodies. Brain tissue homogenate (brain) and normal mouse
serum-immunoprecipitated proteins (mit-IP NM) were used as a positive and a negative control, respectively. (C) Immunoprecipitations with EAAC1
and NCX1 antibodies in SH-SY5Y and C6 cells, respectively. In the immunoblot analysis with NCX1 antibody the IP lane corresponds to EAAC1-
immunoprecipitated protein extracts; in the EAAC1 immunoblots the IP lane corresponds to NCX1-immunoprecipitated protein extracts. Protein
extracts from rat brain tissue homogenate and from BHK cells stably expressing NCX1 were used as controls. In each IP lane, the lower band at
around 50 KDa represents the immunoglobulin. (D) Results from confocal microscopy analysis using NCX1 antibody and the mitochondrial marker
MitoTracker on rat hippocampal and cortical mitochondria are shown on the left. Results on the same mitochondrial preparations probed with EAAC1
(red) and NCX1 (green) antibodies are shown on the right. Note the strong overlap of the two signals in the merged image.
doi:10.1371/journal.pone.0034015.g010
Figure 11. Glutamate-stimulated ATP synthesis relies on NCX1. Selective loss of glutamate-stimulated ATP synthesis in SH-SY5Y (A) and C6
cells (B) exposed to NCX1 AsODNs and its persistence in cells treated with NCX2 or NCX3 AsODNs. Bars represent the mean 6 SEM of 12 different
determinations. Ctl: cells treated with Lipofectamine; S-NCX and As-NCX: cells treated respectively with specific sense and antisense ODNs. * p,0.05
vs control; *** p,0.001 vs control and vs S+glutamate; n.s.: not significant vs control.
doi:10.1371/journal.pone.0034015.g011
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glutamate on mitochondrial metabolism we used an AsODN
approach (Figure S2) [53]. NCX1 knock-down induced the same
effect as CGP-37157, abrogating glutamate-induced ATP synthe-
sis both in SH-SY5Y neuroblastoma (Figure 11A), and in C6
glioma (Figure 11B) cells, whereas NCX2 and NCX3 knock-down
[53] was wholly ineffective (Figure 11A and B).
Finally, it is noteworthy that results obtained in isolated
mitochondria were strengthened by experiments performed in
hippocampal and cortical slices, a well-known integrated system
which largely preserves the tissue architecture and physiology of
brain regions. In this system, DL-TBOA and CGP-37157
completely counteracted glutamate-stimulated ATP synthesis (data
not shown).
Glutamate-induced ATP synthesis in isolated heart
mitochondria is dependent on EAAC1 and NCX1
To further assess the possible physiological importance of the
EAAC1-NCX1 interplay in sustaining ATP production, we sought
for this phenomenon in other tissues. We started by exploring the
Figure 12. Glutamate-induced ATP synthesis in isolated heart mitochondria is dependent on EAAC1 and NCX1. (A) Mitochondria
isolated from rat heart express EAAC1 and NCX1. Plasma membrane (m) and mitochondrial (mt) protein extracts from rat heart were resolved with
EAAC1 and NCX1 antibodies. Blots are representative of a group of 3 different experiments. (B) Coimmunoprecipitation of EAAC1 and NCX1 in rat
mitochondrial protein extracts. Crude protein extracts or proteins separated by immunoprecipitation with NCX1 antibody (IP-NCX1) were resolved
with EAAC1 antibody. In A and B, proteins from whole rat brain were used as a positive control. In each IP lane, the lower band at around 50 KDa
represents the immunoglobulin. (C) Glutamate stimulates ATP synthesis in isolated rat heart mitochondria. The bar graphs show ATP production in
presence of 1 mM glutamate (black bars) or vehicle (white bars) for 1 h in with or without oligomycin. Each bar represents the mean 6 SEM of data
from at least 3 different experimental sessions. (D, E) Glutamate-induced ATP synthesis in rat heart mitochondria is inhibited by EAAT or NCX
pharmacological blockade with DL-TBOA or CGP-37157, respectively. The bar graphs show ATP production in presence of 1 mM glutamate (black
bars) or vehicle (white bars) for 1 h with or without different concentrations of DL-TBOA (panel D) or of CGP-37157 (panel E). Each bar represents the
mean 6 SEM of data from 6 different experimental sessions. ATP data were normalized to the protein content of the different mitochondrial
preparations. *p,0.05 vs control; *** p,0.001 vs control; # p,0.05 vs 1 mM glutamate; ### p,0.001 vs 1 mM glutamate.
doi:10.1371/journal.pone.0034015.g012
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reactivity in mitochondria obtained from rat heart for both
EAAC1 and NCX1 proteins (Figure 12A). Notably we found that,
as in brain, NCX1 and EAAC1 proteins were assembled into a
multimolecular complex (Figure 12B) and that glutamate was able
to stimulate ex novo ATP synthesis (Figure 12C) in a DL-TBOA
(Figure 12D) and CGP-37157 (Figure 12E) sensitive manner.
Glutamate-induced ATP synthesis in undifferentiated
PC12 cells and in liver does not rely on EAAT and NCX1
Undifferentiated PC12 cells express EAAC1 (Figure 13A) but
not NCX1 (Figure 13B). Conversely, NCX2 and NCX3 were
detected (Figure 13C and D). When mitochondria obtained from
PC12 cells were exposed to glutamate, an increase in ATP
synthesis occurred (Figure 14A). However this phenomenon was
independent from EAAC1 and NCX, since neither DL- TBOA
nor CGP-37157 were able to inhibit glutamate-stimulated ATP
synthesis (Figure 14A and B). Equivalent results were obtained in
liver mitochondria, a system that does not express exchangers at
all [54] (Fig. 15B), but does express EAAC1 protein (Figures 15A–
D).
We note that, at the concentrations used here, these two
blockers were unable to block the ATP response to glutamate in
mitochondria from both undifferentiated PC12 cells and rat
hepatocytes (Figure 14 and Figure 15C and D). Since in these cells
NCX1 is not expressed (Figure 13 and Figure 15 A and B) and,
consequentely, the proposed EAAC1/NCX1 mechanism for the
glutamate response is not working (as shown with EAAC1 and
NCX1 AsODN experiments, Figure 3 and Figure 11), these results
strongly suggest that the pharmacological inhibition of the ATP
response is not due to any side actions of DL-TBOA or CGP-
37157 on other mitochondrial carriers.
Conclusion
The findings of the present study disclose a new selective
structural and functional relationship in mitochondria between
EAAC1 and NCX1 transporter subtypes in glutamate-induced
energy production. The reliability of this paper is mainly based on
the purity of the mitochondrial preparation; we provide a large
body of evidence that strongly support the absence of any
contaminants. First of all we characterized the mitochondrial
fraction by immunoblot studies aimed to test the presence or
absence of calnexin (an endoplasmic reticulum marker [55]), b1
integrin (a plasma membrane marker [56]), porin (an outer
mitochondrial membrane marker [57]) and ANT (another
mitochondrial marker [52]). As shown in Figure 1A, our data
suggest that purified mitochondria are free from any contamina-
tion from other organelles or plasma membrane fraction. In
addition, the purified mitochondrial fraction does not contain any
contamination from the cytosol, as suggested by the failed attempt
to stimulate ATP synthesis by using glucose (Figure 1C and S1).
This last observation is also strengthened by the lack of LDH
activity observed in the mitochondrial preparation rather than in
the crude homogenate (data not shown). The data presented here
were obtained in mitochondria from neuronal and glial cells;
interestingly the EAAC1-NCX1 interplay was also documented in
mitochondria from other tissues, such as rat heart, where, as in
brain, the two proteins are assembled into a multimolecular
complex and glutamate induced ATP synthesis in a DL-TBOA-
and CGP-37157-sensitive manner (Figures 12A–E). These findings
suggest that the mechanism outlined above could be a fairly
general phenomenon in tissues where mitochondria coexpress
EAAC1 and NCX1; in our opinion the characterization of this
mitochondrial multimolecular complex represents a pivotal finding
of the paper. It is now generally recognized that a well controlled
ion transporting process across the membrane requires a spatial
interaction between transporters and their modulators, thus
Figure 13. Undifferentiated PC12 cells do express EAAC1 but not NCX1. (A) EAAC1 is expressed in mitochondria from undifferentiated PC12
cells. The panel shows the results of western blot (left) and PCR (right) experiments demonstrating the presence, respectively, of EAAC1 protein and
transcripts in mitochondria isolated from undifferentiated PC12 cells. Significant GLAST expression and undetectable GLT1 levels were observed in
similar experiments (data not shown). The experiments are representative of a set of 3. (B) NCX1 is undetectable in undifferentiated PC12 cells. Note
the absence of NCX1 immunoreactivity even though the blot was overexposed in the attempt to visualize even a faint NCX1 signal (left). Moreover,
no NCX1 mRNA was detected (right). Western blot experiments with NCX1 antibody were not performed on mitochondrial extracts, since we found
no evidence of NCX1 expression in this cell line. In each IP lane, the lower band at around 50 KDa represents the immunoglobulin. (C,D) Both NCX2
and NCX3 are expressed in undifferentiated PC12 cells.
doi:10.1371/journal.pone.0034015.g013
Figure 14. Glutamate induces ATP synthesis in undifferentiat-
ed PC12 cells in an EAAT- and NCX-independent manner.
Glutamate-induced ATP synthesis in undifferentiated PC12 mitochon-
dria is unaffected by EAAT or NCX pharmacological blockade with DL-
TBOA (A) and CGP-37157 (B), respectively. The bar graphs show ATP
production in the presence of 1 mM glutamate (black bars) or vehicle
(white bars) for 1 h with or without DL-TBOA (panel A) or CGP-37157
(panel B). Each bar represents the mean 6 SEM of data from 8 different
experimental sessions. ATP data were normalized to the protein
content of the different mitochondrial preparations. *p,0.05 vs control.
doi:10.1371/journal.pone.0034015.g014
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been shown that in energized mitochondria the matrix Na
+
concentration is lower than extra-mitochondrial one [58], we
propose that this gradient might be the driving force that allows
glutamate entry through EAAC1 and then the interaction with
NCX1 might be crucial to re-establish the Na
+ gradient across the
mitochondrial membrane, that likely has been lost after glutamate
entry.
However, the mechanism underpinning glutamate-stimulate
ATP synthesis could have a versatile regulation, since in our
experience this phenomenon was, conversely, insensitive to CGP-
37157 –hence independent on the EAAC1-NCX1 interaction– in
mitochondria isolated from cells expressing NCX2 and NCX3 but
not NCX1, like undifferentiated PC12 cells (Figures 13A–D,
Figure 14A and B); it was also insensitive to CGP-37157 in
mitochondria isolated from cells not expressing the exchangers at
all, like rat hepatocytes (Figures 15A–D). Notably, in these latter
systems DL-TBOA was unable to counteract the ATP response to
glutamate that presumably involves different mechanisms (like
AGCs).
The mitochondrial ATP response described in this paper seems
not to be influenced by the availability of other metabolic
substrates such as malate and pyruvate. In fact, the glutamate-
dependent component of such response was observed irrespective
of background sub-saturating or saturating malate plus pyruvate
levels (Figure 2A and B). A similar stimulatory effect of glutamate
has recently been reported by Panov and coll [10]. that showed
metabolic response in isolated brain mitochondria already
saturated with Krebs cycle intermediates.
Interestingly, we show that the glutamate effect was selectively
abolished in the presence of the specific EAATs inhibitor TFB-
TBOA (Figure 2A and B), while the ATP stimulation induced by
malate and pyruvate was unaffected (Figure 2A and B). In
connection to these results, we want to underlie that in intact cell
systems such as SH-SY5Y and C6, where metabolic substrates are
present at physiological concentrations, glutamate was able to
induce an ATP response selectively blocked by EAAC1-AsODNs
(Figure 3C). Notably, such response was unaffected by AGC2-
AsODNs (Figure 3D). In addition, the glutamate metabolic
response via EAATs seems to be completely counteracted when
EAATs pharmacological blockers were used (Figure 1D), strength-
ening the requirement of a functional mitochondrial EAAC1.
NCX is an extensively studied protein in its role and previous
works have proposed that the coupled Na
+/Ca
2+ countertransport
Figure 15. Glutamate-induced ATP synthesis in rat liver mitochondria is independent on EAAT and NCX. (A) Mitochondria isolated from
rat liver express EAAC1 and GLT1, but not GLAST. The panel shows three different western blot experiments performed using GLAST, GLT1 and
EAAC1 antibodies on whole lysate or mitochondrial (mt) protein extracts from rat liver. Blots are representative of 3 different experiments. (B)
Mitochondria isolated from rat liver do not express NCX1, NCX2 or NCX3. The panel shows 3 different western blot experiments, each representative
of 2 sets of experiments performed with protein extracts from rat liver mitochondria blotted with NCX1, NCX2 and NCX3 antibodies. None of the NCX
isoforms were expressed in rat liver mitochondria. In A and B, protein extracts from rat hippocampus or cortex were used as a positive control. In each
IP lane, the lower band at around 50 KDa represents the immunoglobulin. (C, D) Glutamate-induced ATP synthesis in rat liver mitochondria is
unaffected by EAAT or NCX pharmacological blockade with DL-TBOA and CGP-37157, respectively. The bar graphs show ATP production in the
presence of 1 mM glutamate (black bars) or vehicle (white bars) for 1 h with or without DL-TBOA (C) or CGP-37157 (D). Each bar represents the mean
6 SEM of data from 8 different experimental sessions. ATP data were normalized to the protein content of the different mitochondrial preparations.
*p,0.05 vs control.
doi:10.1371/journal.pone.0034015.g015
Mitochondrial NCX1/EAAC1 Sustain Brain Metabolism
PLoS ONE | www.plosone.org 16 March 2012 | Volume 7 | Issue 3 | e34015mechanism in mitochondria may modulate the cellular energy
production according to functional requirements (reviewed in
[22]). We have recently shown that the three gene products of the
plasma membrane NCX, namely NCX1, NCX2 and NCX3,
display a specific mitochondrial distribution [22,23,24] and may
participate to the mitochondrial Na
+/Ca
2+ exchange. In the
present paper we provide evidences suggesting that only NCX1
activity is crucial for ATP synthesis sustained by glutamate via
EAAC1, as demonstrated by its abrogation by pharmacological
blockade and selective NCX1 knock-down with AsODNs.
In conclusion, glutamate transported into the cell seems to
activate the energy metabolism by a direct action on mitochondria
both in neurons and in glia. It is well established that glutamate
can be used as substrate to sustain mitochondrial ATP production.
However, to the best of our knowledge, this is the first time that it
has been shown that in mitochondria EAAC1, together with
NCX1, may represent another way by which glutamate enters
mitochondria to sustain ATP production. In fact our data suggest
that this energy production mechanism relies on the selective
interaction between a specific EAAT subtype, EAAC1, and a
specific NCX subtype, NCX1. Their physical association,
disclosed by their coimmunoprecipitation and colocalization,
emphasizes the high selectivity of the interaction. The significance
of the two transporters appearing in a functional complex is, to
date, not fully understood. The mitochondrial localization of
EAAC1 and NCX1 suggests that such complex could be a novel
and complementary mechanism enhancing neuronal metabolism
to meet the increased demand from the activation of the
glutamatergic system. This mechanism could have important
implications in conditions of glutamate overload, particularly in
brain ischemia, where extracellular glutamate concentrations are
significantly increased [59].
Intriguingly, the traditional view of a predominantly harmful
effect of glutamate in stroke and neurotrauma has recently been
questioned by studies suggesting that the neurotransmitter, which
contributes to cell death immediately after traumatic or ischemic
injury, could be essential for recovery at later stages [60]. It is thus
tempting to speculate that the ability of glutamate to enhance
mitochondrial ATP synthesis might later contribute to energy
production restoration, especially when the oxygen tension is not
so low as to abolish oxidative metabolism, as observed in the
ischemic penumbra and in recovery after stroke; however further
studies are needed to assess this hypothesis.
Materials and Methods
Isolation of plasma membranes and mitochondria from
rat tissues and cell cultures
The experiments were performed on whole lysates, plasma
membrane and mitochondrial preparations from rat tissues or
from continuous cell lines, i.e. SH-SY5Y human neuroblastoma,
C6 rat glioma, rat pheochromocytoma undifferentiated PC12 cells
(American Type Culture Collection), and baby hamster kidney
(BHK) cells stably expressing NCX1 (kindly provided by Dr. H.
Porzig). Rat tissues were from adult Wistar rats (200–300 g)
housed and used in strict accordance with the guidelines of the
Italian Ministry of Health (D.L. 116/92 and D.L. 111/94-B), the
Declaration of Helsinki, and the Guide for the Care and Use of
Laboratory Animals, as adopted and promulgated by the National
Institutes of Health (USA). The animals were sacrificed by
decapitation under ether anesthesia, and brain, liver and heart
were quickly removed and processed as appropriate. All efforts
were made to minimize suffering of animals. This study, #1FAR/
06-06 ‘‘Ruolo svolto dallo scambiatore Na
+-Ca
2+ e dai trasporta-
tori del glutammato Na
+-Dipendenti nella produzione di ATP nel
cuore e nel cervello’’ was approved by University ‘‘Politecnica
delle Marche’’ ethics committee during the meeting of October
the 26
th, 2006, Protocol number 28477-November the 21
st, 2006.
Crude membrane fractions were obtained from isolated tissues
as previously described [61] and used for immunoprecipitation
and immunoblotting. Mitochondria used in western blot experi-
ments were collected and purified by discontinuous Percoll
gradient as previously described [23,62]. The purity of the
mitochondrial preparations was checked by evaluating protein
expression of mitochondrial [63] and plasma membrane markers
(see below for further details).
To obtain mitochondria for functional studies from rat tissues
we used previously described protocols [64,65,66] with some
modifications. Briefly, rat tissues were homogenized in a buffer
(8 ml/g of tissue) containing (in mM): sucrose, 320; K-EDTA, 1;
BSA, 0.1%; and Tris-HCl, pH 7.2 with KOH, 10. Nuclei and
other cell debris were sedimented at 5006g for 8 min at 4uC. The
supernatant was centrifuged at 8,0006g for 15 min at 4uC. The
mitochondrial pellet was resuspended and re-centrifuged at
8,0006 g for 15 min at 4uC in a second buffer containing (in
mM): sucrose, 320; K-EDTA, 1; and Tris-HCl, 10, pH 7.4.
Functional mitochondria from cell cultures were obtained as
reported previously by Almeida and Medina [67]. The purity of
the mitochondrial preparations was checked by measuring LDH
activity retained in the whole homogenate and in the isolated
mitochondria [67]. Isolated mitochondria were checked for
viability by MTT assay and used within 1–3 h. Briefly,
mitochondria were incubated with the assay solution (see below
for further details) in the presence of 0.5 mg/ml of MTT (Sigma)
solution and incubated for 30 minutes at 37uC. Then 100 mlo f
DMSO were added to solubilize the formazan produced by
healthy mitochondria. Therefore the amount of formazan
produced is proportional to the number of living mitochondria.
The absorbance was read at 540 nm in a plate reader (Victor
Multilabel Counter, Perkin Elmer).
Western blot and immunoprecipitation studies
Whole cell and tissue lysates for western blot analysis were
obtained using standard techniques and a cell lysis solution
containing (in mM): NaCl, 150; Tris-HCl (pH 7.4), 10; EDTA
(pH 8.0), 1; SDS, 1%, and a protease inhibitor cocktail mixture
(Roche Diagnostics). The purity of mitochondrial preparations was
checked as follow. Protein extracts from both isolated mitochon-
dria and whole tissues were divided into 4 aliquots (50 mgo f
proteins/each) that were resolved by SDS-PAGE on 8%
polyacrylamide gels and then analyzed by western blot [61] with
goat anti-calnexin (1:350; Santa Cruz), mouse anti-b1-integrin
(1:500; Santa Cruz), rabbit anti-porin (1:1000, Calbiochem) and
goat anti-ANT (1:500; Santa Cruz) primary antibodies, respec-
tively. To verify the amount of loaded proteins some filters were
blotted with mouse anti b-tubulin antibody (1:10000, Sigma).
Membrane and mitochondrial proteins from rat tissues and cells
were immunoprecipitated by using commercially available mouse
monoclonal IgG antibodies directed against EAAC1 (1:50;
Chemicon International) [68,69] or NCX1 (R3F1, 1:50; Swant)
[23]. To recover the immunocomplexes, the samples were
incubated with A-Sepharose beads (GE Healthcare). This method
has been already used to analyze protein complex from
mitochondria [70,71]. The following primary antibodies were
used to blot the membranes: mouse anti-EAAC1 (1:1000)
[61,72,73], rabbit anti-GLAST and rabbit anti-GLT1 (both used
at 1:1000 dilution and purchased from Alpha Diagnostic
International), mouse anti-NCX1 (1:500; Swant), anti-NCX2
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Porzig), rabbit anti-NCX3 (1:1000; Swant), and goat anti-ANT
(1:500; Santa Cruz), goat anti-AGC2 (1:500; Santa Cruz). A
ChemiDoc station and the Quantity one analysis software (Bio-
Rad) were used for signal detection and analysis.
Tissue mitochondria immunohistochemistry
Mitochondria derived from rat hippocampus or cortex by
discontinuous Percoll gradient [23] were spotted onto poly-L-
lysine-coated micro slides by cytocentrifugation. Half of the
preparation was then loaded with 2 mM Red MitoTracker
(Invitrogen) for 15 min. Then, mitochondria were fixed in 4%
PFA (15 min at 37uC), permeabilized in PBS with 10% normal
rabbit serum and 0.1% Triton for 1 h at room temperature,
washed in PBS and incubated overnight at 4uC with the primary
antibodies goat anti-EAAC1 (1:1000; Chemicon International)
and/or mouse anti-NCX1 (1:500) in PBS with 1% normal rabbit
serum. After washing, mitochondria were incubated with anti-
mouse Alexa Fluor 488 dye-conjugated antibody (1:500) or anti-
goat Alexa Fluor 555 dye-conjugated antibody (1:500; both from
Molecular Probes) at room temperature for 1 h. The fluorescent
signal was visualized using an LSM 510 laser scanning confocal
microscope (Carl Zeiss) equipped with an Argon (for the Alexa
Fluor 488 dye) and a HeNe (for MitoTracker Red and the Alexa
Fluor 555 dye) laser.
EAAC1 pre-embedding immunoelectron microscopy
Adult male Wistar rats were anesthetized with 12% chloral
hydrate and perfused transcardially with 4% paraformaldehyde
and 0.5% glutaraldehyde in 0.1 M phosphate buffer (PB), or non-
immune serum as negative control (data not shown) and then
sections were incubated in the appropriate goat biotinylated
secondary antibodies; diaminobenzidine was used as chromogen
[74]. After completion of immunohistochemical staining, sections
were washed in PB, incubated in 2.5% glutaraldehyde (1 h at
4uC), washed in PB and postfixed in 1% OsO4 (1 h at 4uC). After
dehydration in ethanol and infiltration in Epon-Spurr resin,
sections were flat-embedded between acetate sheets (Aclar, Ted
Pella, Redding, CA) and polymerized at 60uC for 48 h. The
embedded sections were then examined under a dissecting
microscope. Small tissue strips containing the cerebral cortex or
the hippocampus were cut out, glued to blank epoxy and sectioned
with an MTX ultramicrotome (RMC, Tucson, AZ). Thin sections
were stained with lead citrate and examined in a Philips CM10
transmission electron microscope (Eindhoven, The Netherlands).
Real-time confocal imaging
Analysis of mitochondrial inner membrane potential. SH-SY5Y
and C6 cells grown for 18 h on poly-L-lysine-coated glass
coverslips were loaded at 37uC with 150 nM tetramethylrhoda-
mine ethyl ester (TMRE) (Invitrogen) [41,42,43,75]. In these
conditions, after mitochondrial depolarization, TMRE is released
from the quenched matrix to the cytoplasm, resulting in an
increase in cytoplasmic fluorescence. After 20 min cells were
washed and transferred to a microscopy chamber in standard
buffer solution in the presence of 150 nM TMRE. Confocal
images were obtained using the 510 LSM microscope equipped
with a META detection system and a 406oil immersion objective.
Illumination intensity was kept to a minimum (0.1–0.2% of laser
output) to avoid phototoxicity; the pinhole was set to give an
optical slice of ,1 mm. TMRE was excited at 543 nm and
fluorescence was measured from 580 nm to 700 nm in cytoplas-
mic regions of interest (ROIs). For data analysis fluorescence was
expressed as ratios (F/F0) of fluorescence counts (F) relative to
baseline values before stimulation (F0). In a separate set of
experiments, cells were loaded with 10 nM TMRE at 37uCi n
culture medium. Prior to the measurements cells were then
permeabilized for 10 min with digitonin 5 mM in ‘‘intracellular’’
buffer with the following composition (mM): 5 NaCl, 100 KCl, 70
mannitolo, 25 sucrose, 10 KH2PO4, 0.0001 CaCl2, 10 Tris-HCl,
1 MgCl2, 5,5 glucose, 2 pyruvate, 2 malate, 3 succinate, 0.1 ADP,
0.005 digitonin, 0.00001 TMRE, pH 7.3/KOH. Digitonin has
been already used to selectively permeabilize the plasma
membrane of a wide variety of cells without affecting cellular
organelles such as mitochondria [76,77,78]. Cells on coverslips
were then perfused with ‘‘intracellular’’ medium containing
TMRE (10 nM) and digitonin (5 mM) at constant rate and
fluorescence imaging was started. In contrast to the increase in
fluorescence in TMRE that occurs with a decreased DYmit of cells
in the quenching conditions, in this set of experiments the TMRE
fluorescence of individually imaged cell bodies proportionally
decreases with mitochondrial membrane depolarization. When
DL-threo-b-benzyloxyaspartic acid (DL-TBOA) (300 mM) or
CGP-37157 (3 mM) were used, they were added starting from
the permeabilization step throughout the end of the experiments.
The Mg
2+ concentration in the ‘‘intracellular’’ medium is expected
to block the mitochondrial uniporter [79].
Glutamate and/or added drugs were diluted in the perfusion
medium and applied by switching the reservoirs of the perfusion
system.
Analysis of Na
+
mit.N a
+
mit changes were monitored in intact
cells as described previously [48]. Briefly, SH-SY5Y and C6 cells
were loaded with 1 mM CoroNa Red (Invitrogen) [48] in serum-
free culture medium for 15 min at 37uC. The pinhole was set to
give an optical slice of ,1 mm. CoroNa Red was excited at
543 nm and fluorescence emission was measured from 560 nm to
615 nm. ROIs excluding nuclei with a high density of mitochon-
dria were selected in individual cells and the average fluorescence
signal within these regions was analyzed over time. For each data
point we obtained SEM values that were smaller than 7% of the
corresponding fluorescence mean values.
Analysis of mitochondrial calcium (Ca
2+
mit). Ca
2+
mit changes
were monitored in cells permeabilized as described above. Briefly,
SH-SY5Y and C6 cells were loaded with 5 mM Rhod-2 AM
(Invitrogen) in culture medium for 60 min at 37uC. To remove the
fluorescence contribution of the cytosolic component, cells were
permeabilized with digitonin 5 mM in intracellular buffer contain-
ing 300 nM (for C6 cells) or 400 nM (for SH-SY5Y cells) CaCl2.
Rhod-2 was excited at 543 nm and fluorescence emission was
measured from 560 nm to 600 nm.
Analysis of ATP production
ATP production was evaluated using a commercially available
luciferase-luciferin system (ATPlite, Perkin Elmer). Isolated mito-
chondria. Mitochondria were incubated in a solution containing (in
mM): KCl, 100; NaCl, 5; CaCl2, 0.0001; mannitol, 75; sucrose,
25; KH2PO4 (pH 7.4 with Tris), 10; Tris-HCl, 10; and ADP, 0.1,
with or without 0.5–1 mM glutamate. In preliminary experiments
these glutamate concentrations gave the maximal response in
terms of stimulation of ATP synthesis without toxic effects in our
systems (data not shown). The tested drugs or the respective
vehicles were added to mitochondrial suspensions 15 min before
glutamate stimulation and throughout the experiments. Lumines-
cence was measured with a luminescence counter (Victor Multi-
label Counter, Perkin Elmer). All experiments were performed
using ,60 mg of mitochondria, an amount that in preliminary
tests ensured strong and reproducible ATP signal, and 1 h
incubation, which in the same preliminary tests provided the best
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lation. The magnitude of ATP response to glutamate alone was
found to vary between mitochondrial preparations. Therefore, for
each set of experiments, for each experimental session, every batch
of mitochondrial preparations was used and divided in the
following groups: unstimulated, stimulated with glutamate, treated
with tested drugs 6 glutamate, as indicated. Cultured cells. Cells,
24 h after been plated in 96 multiwell plates (30,000/well), were
transfected with ODNs for additional 24 h for NCX1 or EAAC1
and 48 h for Citrin/AGC2 knock-down experiments. Afterward
they were first washed with standard buffer solution containing (in
mM): NaCl, 140; KCl, 5; CaCl2, 1; MgCl2, 0.5; HEPES, 10; and
glucose, 5.5, pH 7.4, adjusted with Tris, and then exposed to
glutamate (0.5–1 mM) in standard buffer solution for 1 h at 37uC.
ATP levels were analyzed after incubation. All ATP data were
normalized to the protein content of the different preparations.
ODN experiments
Chimeric phosphorothioated sense and antisense (As) oligonu-
cleotides (ODNs) against rat (GenBank Accession Number
NM_013032 XM_346583) or human EAAC1 (GenBank Acces-
sion Number NM_004170) and a mixture of two chimeric
phosphorothioated sense and antisense ODNs against rat
(GenBank Accession Number XM_342640) or human Citrin/
AGC2 (GenBank Accession Number NM_014251) were designed
to target the area near the start region of the genes (Table 1) and
used as reported previously [53] to knock down respectively
EAAC1 and Citrin/AGC2. SH-SY5Y or C6 cells were transfected
with Attractene (Qiagen) or Lipofectamine 2000 (Invitrogen) using
standard protocols. Transfection efficiency was quantified using a
plasmid encoding the enhanced green fluorescent protein
cotransfected with ODNs. The efficiency of the gene silencing
obtained with AsODNs was measured by real-time PCR and
averaged at 60%, both for EAAC1 and for Citrin/AGC2.
Chimeric phosphorothioated sense and antisense ODNs were
used to knock down the different NCX subtypes as described
previously [53]. The protein levels of NCX1, EAAC1 and ACG2
were selectively decreased (30–40%, 3 independent experimental
sessions) in SH-SY5Y and C6 cells treated with the respective As-
ODN (but not with the respective S-ODN; Figure S2). As-ODNs
used to specifically knock-down only one of the three transporters
(i.e. NCX1, EAAC1 or AGC2) were without effect on the protein
levels of the two other ones.
PCR analysis
Real-time PCR was performed as described previously [61].
Primers for cDNA amplification of EAAC1, Citrin/AGC2 and the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were selected according to the rat sequences available
in GenBank, in a region with high homology to the human genes
(Table 1). Primer optimization, i.e. dimerization, self-priming and
melting temperature, was carried out with Primer Express (v. 1.5;
Applied Biosystems). Gene-specific primers were blasted against
the GenBank to confirm their species and gene specificity; the
melting curve was used to determine the specificity of each primer.
All samples from different experiments were analyzed in triplicate
in two assays to verify assay reproducibility, and the mean values
of each point were used for gene expression quantification.
Analysis of the melting curve confirmed the specificity of the PCR
products (data not shown). When reverse transcription PCR
analysis was needed, it was performed as previously described [53]
by using primers shown in Table 1.
Statistical analysis
Data were expressed as mean 6 SEM. p,0.05 was considered
significant. Differences among means were assessed by one-way
ANOVA followed by Dunnet’s post hoc test. For experiments
performed in pair-wise fashion, significance of results was
determined by Student’s t-test.
Drugs and chemicals
DL-TBOA, (3S)-3-[[3-[[4 (trifluoromethyl)benzoyl]amino]phe-
nyl]methoxy]-L-aspartic acid (TFB-TBOA) and CGP-37157 were
obtained from Tocris. Ru360 (Calbiochem) was dissolved in ultra
pure distilled water (previously saturated for 1 h with 95% N2 and
5% CO2) at final concentration of 10 mM and used immediately
after. All the other chemicals were of analytical grade and were
purchased from Sigma.
Supporting Information
Figure S1 Glucose fails to stimulate ATP production in
SH-SY5Y and C6 mitochondria. ATP production in SH-
SY5Y (A) or C6 cells (B) in mitochondria (left) and in whole cells
(right) after 1 h incubation with glutamate (black bars), glucose
(grey bars) or vehicle (white bars). Each bar represents the mean 6
SEM of data from at least 3 different experimental sessions. ATP
data were normalized to the protein content of the different
preparations *p,0.05 vs control; *** p,0.001 vs control.
(TIF)
Figure S2 Effect of NCX1, EAAC1 and ACG2 ODNs
transfection in SH-SY5Y and C6 glioma cells. Specific AS-
ODNs for NCX1, EAAC1 and ACG2 decreased the expression of
the respective protein both in SH-SY5Y (A) and C6 (B) cells. The
extent of protein reduction was around 30–40%. Notably, S-
ODNs did not affect protein basal expressions (A,B), confirming
the selectivity of our antisense ODNs. The experiments showed
are representative of a set of 3. b-tubulin was used as western blot
internal control.
(TIF)
Figure S3 Failure of the mitochondrial protein ANT to
immunoprecipitate with EAAC1 or NCX1 in either
hippocampal or cortical mitochondria. (A,B) Mitochondria
from rat hippocampus and cortex express ANT. Coimmunopre-
cipitation of ANT with EAAC1 (A) or with NCX1 (B) in rat
mitochondrial protein extracts: crude protein extracts (mt) or
proteins immunoprecipitated with EAAC1 (mt-IP-EAAC1, A) or
with NCX1 (mt-IP-NCX1, B) antibodies or with non-immune
serum (mt-IP NM A, B) were resolved with ANT antibody.
Notably ANT did not coimmunoprecipitate with either EAAC1 or
NCX1, confirming that the association of EAAC1 and NCX1
found in mitochondria was a specific phenomenon, not a technical
artifact. In each IP lane, the lower band at around 50 KDa
represents the immunoglobulin.
(TIF)
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